Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2007

IntegraGen Becomes First French Service Provider of Illumina Tools

  • IntegraGen received Illumina Certified Service Provider (CSPro™) certification for GoldenGate® and Infinium® genotyping technologies. IntegraGen reports that the transaction makes it the first certified French service provider for these Illumina technologies. Illumina says that the GoldenGate assay is its first array-based platform that combines high-sample throughput, high multiplexing, and single-site CpG resolution for DNA methylation profiling. The Infinium Whole-Genome Genotyping BeadArray™ solution offers single or multisample BeadChip formats and high-density architecture with the flexibility to add additional custom SNP Assays.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »